See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Natural Disasters
Trade War
Donald Trump
Social Media
Floods
Housing
Taxes
Tennis
Artificial Intelligence
Trade
Published • loading... • Updated

Early Statin Use Shows Sustained Cardiovascular Benefits

Summary by Dataemia
TOPLINE: Early introduction of atorvastatin vs placebo in patients with hypertension demonstrated significant benefits in reducing cardiovascular disease events, such as non-fatal myocardial infarction (MI) and coronary heart disease (CHD) events, over a 20-year follow-up period. METHODOLOGY: Researchers analysed data from the ASCOT lipid-lowering arm study and included 4605 UK participants with hypertension, at least three additional risk fact…

5 Articles

All
Left
Center
1
Right
Hastings TribuneHastings Tribune
Center

Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25

DENVER--(BUSINESS WIRE)--Mar 31, 2025-

Read Full Article
European Medical JournalEuropean Medical Journal

Biologics Offer Heart Protection in Psoriasis

A new study finds that biologic therapies significantly reduce the risk of heart attacks and strokes in patients with psoriasis or psoriatic arthritis. Learn more about the cardiovascular benefits of systemic treatments.

Read Full Article
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Reposted by
DataemiaDataemia

Early Statin Use Shows Sustained Cardiovascular Benefits

TOPLINE: Early introduction of atorvastatin vs placebo in patients with hypertension demonstrated significant benefits in reducing cardiovascular disease events, such as non-fatal myocardial infarction (MI) and coronary heart disease (CHD) events, over a 20-year follow-up period. METHODOLOGY: Researchers analysed data from the ASCOT lipid-lowering arm study and included 4605 UK participants with hypertension, at least […] The post Early Statin U…

Read Full Article
DAICDAIC

Trial Results: Low-Dose Colchicine HelpsTreat Cardiovascular Disease

EKSTROM trial results demonstrate low-dose colchicine, 0.5 mg significantly reduced total plaque volume in stable coronary artery disease compared to placebo at one year.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Hastings Tribune broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal